|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.395 USD | -0.09% |
|
-4.62% | -22.73% |
| 02-23 | Bausch Health Launches New Skin Laser in Canada | MT |
| 02-19 | TSX hits another record high as commodity-linked stocks climb | RE |
| Capitalization | 2B 1.73B 1.56B 1.49B 2.72B 185B 2.8B 18.45B 7.36B 88.23B 7.51B 7.35B 318B | P/E ratio 2026 * |
3.6x | P/E ratio 2027 * | 3.41x |
|---|---|---|---|---|---|
| Enterprise value | 20.08B 17.35B 15.67B 14.98B 27.31B 1,852B 28.08B 185B 73.82B 885B 75.35B 73.76B 3,189B | EV / Sales 2026 * |
1.88x | EV / Sales 2027 * | 1.75x |
| Free-Float |
88.99% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bausch Health Companies Inc.
| 1 day | -0.09% | ||
| 1 week | -4.62% | ||
| Current month | -9.44% | ||
| 1 month | -11.68% | ||
| 3 months | -23.40% | ||
| 6 months | -25.93% | ||
| Current year | -22.73% |
| 1 week | 5.14 |  | 5.76 |
| 1 month | 5.14 | | 6.33 |
| Current year | 5.14 | | 8 |
| 1 year | 4.25 | | 8.68 |
| 3 years | 3.96 | | 11.46 |
| 5 years | 3.96 | | 34.5 |
| 10 years | 3.96 | | 70.43 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 63 | 10/05/2022 |
| Director of Finance/CFO | 60 | 19/08/2024 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Power
CHM | Chairman | 69 | 10/05/2022 |
Thomas Appio
BRD | Director/Board Member | 63 | 10/05/2022 |
Amy Wechsler
BRD | Director/Board Member | 56 | 14/06/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -1.55% | 0.26% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.09% | -4.62% | -23.29% | -32.54% | 2B | |
| -0.60% | -0.70% | +20.93% | +207.10% | 895B | |
| -0.33% | -1.15% | +46.20% | +58.42% | 587B | |
| +0.50% | -3.59% | +6.61% | +49.86% | 401B | |
| -1.55% | -8.03% | +11.30% | +24.88% | 345B | |
| -0.62% | -5.04% | +26.69% | +62.26% | 300B | |
| -1.16% | -4.00% | +26.17% | +35.54% | 306B | |
| -0.72% | -3.44% | +22.61% | +9.85% | 289B | |
| +0.20% | -1.03% | +17.70% | +60.97% | 202B | |
| -1.43% | -1.25% | +27.91% | +84.09% | 184B | |
| Average | -0.67% | -2.38% | +18.28% | +56.04% | 351.25B | |
| Weighted average by Cap. | -0.67% | -1.91% | +23.81% | +87.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.67B 9.22B 8.33B 7.96B 14.51B 984B 14.92B 98.42B 39.23B 471B 40.04B 39.2B 1,695B | 10.68B 9.23B 8.33B 7.97B 14.52B 985B 14.93B 98.49B 39.26B 471B 40.07B 39.23B 1,696B |
| Net income | 223M 192M 174M 166M 303M 20.54B 311M 2.05B 819M 9.82B 836M 818M 35.38B | 598M 517M 467M 447M 814M 55.19B 837M 5.52B 2.2B 26.39B 2.25B 2.2B 95.06B |
| Net Debt | 18.08B 15.62B 14.1B 13.49B 24.59B 1,667B 25.28B 167B 66.46B 797B 67.84B 66.41B 2,872B | 16.74B 14.47B 13.06B 12.49B 22.77B 1,544B 23.41B 154B 61.54B 738B 62.82B 61.5B 2,659B |
Employees
20,300
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/03/26 | 5.375 $ | -0.46% | 913,580 |
| 10/03/26 | 5.400 $ | +0.93% | 1,833,146 |
| 09/03/26 | 5.350 $ | -0.56% | 2,405,875 |
| 06/03/26 | 5.380 $ | -3.41% | 1,765,435 |
| 05/03/26 | 5.570 $ | -1.07% | 1,928,577 |
Sell
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
5.400USD
Average target price
7.714USD
Spread / Average Target
+42.86%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BHC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition